MedTrace Logo

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

NCT06779058 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-27

No results posted yet for this study

Summary

How to construct a non-invasive, accurate, and convenient method to evaluate the severity of liver fibrosis (LF) is an important general problem in the management of patients with chronic hepatitis B (CHB). We plan to investigate the ability of magnetic resonance elastography (MRE) to grade fibrosis in chronic hepatitis B and apply to clinical longitudinal follow-up.

Conditions

Interventions

DEVICE

MRE

All imaging studies were performed by using a 1.5T/3.0-T MRI system

DEVICE

Liver biopsy

Liver biopsy are performed by well-trained pathologists in accordance with standard operating procedures.

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • Yu Shi · Shengjing Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06779058 on ClinicalTrials.gov